An audio webcast of the Company's presentation will be available by clicking here or by visiting the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-stifel-2016-healthcare-conference-300356804.html
SOURCE ViewRay, Inc.